AesMed Co., Ltd. is a cosmetics and medical device manufacturer and sales company specializing in hair loss treatment. For the past 22 years, we have been at the forefront of the domestic and international hair loss markets. Presently, our products are supplied to 7 university hospitals, 500 hospitals, clinics, and major hair transplant centers. To date, 3 million procedures have been conducted with Aesmed’s AGF39, developed in 2008. The cytokine therapy for alopecia with AGF39 is now recognized as the standard mesotherapy solution for alopecia treatment.
South Korea
_2.png)
